| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/01/2008 | US20080103087 Azurin, pseudoazurin, plastocyanin, rusticyanin, Laz or auracyanin from Xylella, Pseudomonas, Alcaligene, Achromobacter, Bordetella, Methylomonas, Neisseria, or Vibrio; anticarcinogenic or antitumor agents; diabetic retinopathy, rheumatoid arthritis, psoriasis |
| 05/01/2008 | US20080102081 Preparations and applications for treatment of high cholesterol levels |
| 05/01/2008 | US20080102071 T cell inhibitory receptor compositions and uses thereof |
| 05/01/2008 | US20080102069 Using pertuzumab or combination trastuzumab and pertuzumab therapies to treat metastatic cell proliferative disorders |
| 05/01/2008 | US20080102068 Mitotic Kinesin Inhibitors |
| 05/01/2008 | US20080102060 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 05/01/2008 | US20080102034 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102033 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102027 Targer For B-Cell Disorders |
| 04/30/2008 | EP1916301A1 Method for evaluating compound using molecule on the rb pathway as index and molecular diagnostic method |
| 04/30/2008 | EP1916257A1 GD2 peptide mimotopes for anticancer vaccination |
| 04/30/2008 | EP1916254A2 17alpha-alkyl-17beta-oxy-estratriene and intermediates for its production, use of 17alpha-alkyl-17beta-oxy-estratriene for manufacturing medicine and pharmaceutical preparations |
| 04/30/2008 | EP1916251A1 Erianin salts, their preparation methods and pharmaceutical compositions containing the same |
| 04/30/2008 | EP1916248A1 Furanone derivatives as cysteine protease inhibitors |
| 04/30/2008 | EP1916247A1 Activator of peroxisome proliferator activated receptor |
| 04/30/2008 | EP1916241A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 04/30/2008 | EP1916003A1 Thymidine analogs for imaging |
| 04/30/2008 | EP1916001A2 Human antibodies specific to KDR and uses thereof |
| 04/30/2008 | EP1915995A1 Aqueous solution preparation containing camptothecins |
| 04/30/2008 | EP1915622A2 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
| 04/30/2008 | EP1915456A1 Cancerous disease modifying antibodies |
| 04/30/2008 | EP1915455A1 Cancerous disease modifying antibodies |
| 04/30/2008 | EP1915448A1 Nucleic acid agents for downregulating h19, and methods of using same |
| 04/30/2008 | EP1915381A1 Boron compounds useful in bnct |
| 04/30/2008 | EP1915377A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
| 04/30/2008 | EP1915374A2 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| 04/30/2008 | EP1915370A1 Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
| 04/30/2008 | EP1915368A1 Salts and polymorphs of a vergf-r inhibitor |
| 04/30/2008 | EP1915363A1 Oxopyridyl quinoline amides as nk3 receptor modulators |
| 04/30/2008 | EP1915362A1 Amide alkyl pyridiyl quinolines as nk3 receptor modulators |
| 04/30/2008 | EP1915361A1 Alkylpyridyl quinolines as nk3 receptor modulators |
| 04/30/2008 | EP1915351A1 Quinazoline derivatives useful in cancer treatment |
| 04/30/2008 | EP1915345A1 Fluoro substituted 2-oxo azepan derivatives |
| 04/30/2008 | EP1915339A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 04/30/2008 | EP1915154A2 Combination of organic compounds |
| 04/30/2008 | EP1915151A2 Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors |
| 04/30/2008 | EP1647599B1 Quantitative method for detecting yessotoxins in fishery products based on the activation caused by the toxin in cellular phosphodiesterase |
| 04/30/2008 | EP1419177B1 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 04/30/2008 | EP1372677B1 Use of compositions comprising sesquiterpene derivatives for the treatment of cancer |
| 04/30/2008 | EP1335725B1 Use of cci-779 as an antineoplastic agent |
| 04/30/2008 | EP1307486B1 Somatostatin analogues |
| 04/30/2008 | EP1294747B1 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 04/30/2008 | EP1212417B1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 04/30/2008 | EP1208116B1 Somatostatin analogs, radiolabelled derivatives thereof and their use |
| 04/30/2008 | CN101171257A Pyrrolobenzodiazepines compound |
| 04/30/2008 | CN101171254A Fused thieno[2,3-B]pyridine and thiazolo[5,4-B]pyridine compounds for inhibiting KSP kinesin activity |
| 04/30/2008 | CN101171245A Indolylamino quinazoline derivatives as antitumor agents |
| 04/30/2008 | CN101171244A Indazolylamino quinazoline derivatives as antitumor agents |
| 04/30/2008 | CN101171236A Antitumoral tetrahydro-pyrimidines |
| 04/30/2008 | CN101171052A Compounds for inhibiting KSP kinesin activity |
| 04/30/2008 | CN101171035A Methods and compositions for modulating TWEAK and FN14 activity |
| 04/30/2008 | CN101171020A Botanical anticancer formulations |
| 04/30/2008 | CN101171013A Use of pyrimidylamimobenzamide derivatives for the treatment of systematic mastocytosis |
| 04/30/2008 | CN101170995A 新颖的脂质体组合物 Novel liposome compositions |
| 04/30/2008 | CN101168742A Oncolytic virus and its preparing method |
| 04/30/2008 | CN101168597A Hollow polymer sub-micron sphere coated with gold case, preparation method and use thereof |
| 04/30/2008 | CN101168538A Annonaceousacetogenins compounds and preparation method thereof |
| 04/30/2008 | CN101168065A Recombination archaea histone HPhA as gene medicine carrier and application in preparing anti-cancer medicine |
| 04/30/2008 | CN101168064A Recombination human pancreatic cancer mucus protein core peptide DNA vaccine |
| 04/30/2008 | CN101168053A Method for preparing self-body large intestine cancer vaccine |
| 04/30/2008 | CN101168008A Medicinal composition with tumor inhibition function and preparation method and application thereof |
| 04/30/2008 | CN101167962A Orally-administered traditional Chinese medicinal formula for treating leukemia |
| 04/30/2008 | CN101167930A Traditional Chinese medicinal preparation for treating digestive system cancer |
| 04/30/2008 | CN101167883A Traditional Chinese medicine compound preparation for preventing gastric cancer metastasis and preparation method thereof |
| 04/30/2008 | CN101167865A Orally-administered traditional Chinese medicinal composition for treating acute leukemia |
| 04/30/2008 | CN101167831A Apple polysaccharide, its preparation method and application in preventing and treating tumor metastasis medicine |
| 04/30/2008 | CN101167821A External-applied traditional Chinese medicine for curing breast cancer and its preparation method |
| 04/30/2008 | CN101167820A External-applied traditional Chinese medicine for curing uterus cancer and its preparation method |
| 04/30/2008 | CN101167792A Fructus psoralea reverse tumor medicines-resistant active component and preparation method thereof and application |
| 04/30/2008 | CN101167789A Tumor recovering capsule and production method thereof |
| 04/30/2008 | CN101167771A Application of vinca flower and its extraction in preparing medicine for resisting AIDS |
| 04/30/2008 | CN101167765A Colon targeting drug delivery soft capsule and preparation method thereof |
| 04/30/2008 | CN101167760A Mushroom fermentation oral liquid with anti-tumor active and preparation method |
| 04/30/2008 | CN101167759A Mushroom fermentation dry powder preparation with anti-tumor active and preparation method |
| 04/30/2008 | CN101167755A Method for preparing centipede polysaccharide protein composition with anti-tumor active and use |
| 04/30/2008 | CN101167746A Anti-tumor biologically active substance and preparation technology thereof |
| 04/30/2008 | CN101167742A Medicine for treating leukemia |
| 04/30/2008 | CN101167741A Sulforaphane and platinum medicine anti-cancer combination preparation |
| 04/30/2008 | CN101167719A Gallo catechin and gallate microcapsule granule and preparation technique thereof |
| 04/30/2008 | CN101167718A Rebescensine A powder injection and preparing process thereof |
| 04/30/2008 | CN101167716A Taxol nanometer particle and preparation method and application thereof |
| 04/30/2008 | CN101167698A Freezing-dried preparation containing pirarubicin |
| 04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
| 04/30/2008 | CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins |
| 04/30/2008 | CN100384982C Antrodia camphorata mycelium fermented extract and application thereof |
| 04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384878C Antibodies specific for human cd22 and their therapeutic anddiagnostic uses |
| 04/30/2008 | CN100384875C 蛋白质 Protein |
| 04/30/2008 | CN100384869C Diisopropoxy phosphoryl dipeptide trimethoxy benzamide compound and its preparation process |
| 04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 04/30/2008 | CN100384855C Poly-substituted flavan zothia dizoline kind compound and preparation process and use thereof |
| 04/30/2008 | CN100384851C Epothilone derivatives |
| 04/30/2008 | CN100384844C Xanthine phosphodiesterase V inhibitor polymorphs |
| 04/30/2008 | CN100384837C Novel farnesyl protein transferase inhibitors as antitumor |
| 04/30/2008 | CN100384836C Novel cyclic amide derivatives |
| 04/30/2008 | CN100384834C Epothilone derivatives |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/30/2008 | CN100384482C Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression |
| 04/30/2008 | CN100384480C Delivery system for nucleic acids |